The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice

Virology

Volumn 324, Issue 2, 2004, Pages 350-360

  Ros, Carlos ^a   Kempf, Christoph ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Cytoplasmic trafficking; MVM; Nuclear transport; Parvovirus; Proteasome inhibitors; Proteasomes; Ubiquitin; Viral protein (VP)

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAPSID PROTEIN; PROTEASOME; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; UBIQUITINATION; VIRUS CAPSID; VIRUS INFECTION; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOSINE TRIPHOSPHATASES; ANIMALS; CAPSID; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; INTRACELLULAR SPACE; LEUPEPTINS; MICE; MINUTE VIRUS OF MICE; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; TIME FACTORS; UBIQUITIN; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; BOVINAE; BOVINE PARVOVIRUS; MICE MINUTE VIRUS; PARVOVIRUS;

EID: 2942752307     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.016     Document Type: Article

References (52)

1. Andrejeva J., Young D.F., Goodbourn S., Randall R.E. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76:2002;2159-2167
2. Asher G., Lotem J., Sachs L., Kahana C., Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. U.S.A. 99:2002;13125-13130
3. Bartlett J.S., Wilcher R., Samulski R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74:2000;2777-2785
4. Clemens K.E., Pintel D.J. The two transcription units of the autonomous parvovirus minute virus of mice are transcribed in a temporal order. J. Virol. 62:1988;1448-1451
5. Corbin-Lickfett K.A., Bridge E. Adenovirus E4-34kDa requires active proteasomes to promote late gene expression. Virology. 315:2003;234-244
6. Cotmore S.F., Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:1987;91-174
7. Cotmore S.F., D'abramo A.M. Jr., Ticknor C.M., Tattersall P. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology. 254:1999;169-181
8. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847
9. Dantuma N.P., Masucci M.G. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. Semin. Cancer Biol. 13:2003;69-76
10. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:1999;9928-9933
11. Dorsch S., Liebisch G., Kaufmann B., von Landenberg P., Hoffmann J.H., Drobnik W., Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 76:2002;2014-2018
12. Douar A.M., Poulard K., Stockholm D., Danos O. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75:2001;1824-1833
13. Duan D., Yue Y., Yan Z., Yang J., Engelhardt J.F. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105:2000;1573-1587
14. Eom C.Y., Lehman I.R. Replication-initiator protein (UL9) of the herpes simplex virus 1 binds NFB42 and is degraded via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 100:2003;9803-9807
15. Hansen J., Qing K., Srivastava A. Infection of purified nuclei by adeno-associated virus 2. Molec. Ther. 4:2001;289-296
16. Hernando E., Llamas-Saiz A.L., Foces-Foces C., McKenna R., Portman I., Agbandje-McKenna M., Almendral J.M. Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles. Virology. 267:2000;299-309
17. Hilt W., Wolf D.H. Proteasomes: the world of regulatory proteolysis. Hilt W., Wolf D.H. Eurekah.com. 2000;Austin and Landes Biosciences, Georgetown, TX
18. Kalejta R.F., Shenk T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl. Acad. Sci. U.S.A. 100:2003;3263-3268
19. Kalejta R.F., Bechtel J.T., Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 23:2003;1885-1895
20. Khor R., McElroy L.J., Whittaker G.R. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic. 4:2003;857-868
21. Krappmann D., Wulczyn F.G., Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J. 15:1996;6716-6726
22. Li Y., Zadori Z., Bando H., Dubuc R., Fediere G., Szelei J., Tijssen P. Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid. J. Gen. Virol. 82:2001;2821-2825
23. Littlefield J.W. Three degrees of guanylic acid-inosinic acid pyrophosphorylase deficiency in mouse fibroblats. Nature. 203:1964;1142-1144
24. Lombardo E., Ramirez J.C., Agbandje-McKenna M., Almendral J.M. A beta-stranded motif drives capsid protein oligomers of the parvovirus minute virus of mice into the nucleus for viral assembly. J. Virol. 74:2000;3804-3814
25. Lopez-Bueno A., Mateu M.G., Almendral J.M. High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host. J. Virol. 77:2003;2701-2708
26. Lukashov V.V., Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J. Virol. 75:2001;2729-2740
27. Luo H., Zhang J., Cheung C., Suarez A., McManus B.M., Yang D. Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am. J. Pathol. 163:2003;381-385
28. Michalek M.T., Grant E.P., Rock K.L. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation. J. Immunol. 157:1996;617-624
29. Miller C.L., Pintel D.J. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation. Virology. 285:2001;346-355
30. Niedermann G. Immunological functions of the proteasome. Curr. Top. Microbiol. Immunol. 268:2002;91-136
31. Ott D.E., Coren L.V., Sowder R.C., Adams J., Nagashima K., Schubert U. Equine infectious anemia virus and the ubiquitin-proteasome system. J. Virol. 76:2002;3038-3044
32. Ott D.E., Coren L.V., Sowder R.C., Adams J., Schubert U. Retroviruses have differing requirements for proteasome function in the budding process. J. Virol. 77:2003;3384-3393
33. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 78:1994;773-785
34. Patnaik A., Chau V., Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U.S.A. 97:2000;13069-13074
35. Patnaik A., Chau V., Li F., Montelaro R.C., Wills J.W. Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J. Virol. 76:2002;2641-2647
36. Rape M., Jentsch S. Taking a bite: proteasomal protein processing. Nat. Cell Biol. 4:2002;113-116
37. Rock K.L., Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:1999;739-779
38. Ros C., Burckhardt C.J., Kempf C. Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J. Virol. 76:2002;12634-12645
39. Schubert U., Ott D.E., Chertova E.N., Welker R., Tessmer U., Princiotta M.F., Bennink J.R., Krausslich H.G., Yewdell J.W. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U.S.A. 97:2000;13057-13062
40. Seisenberger G., Ried M.U., Endress T., Buning H., Hallek M., Brauchle C. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science. 294:2001;1929-1932
41. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., Clurman B.E. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell. 5:2000;403-410
42. Shein H.M., Enders J.F. Multiplication and cytopathogenicity of Simian vacuolating virus 40 in cultures of human tissues. Proc. Soc. Exp. Biol. Med. 109:1962;495-500
43. Strack B., Calistri A., Accola M.A., Palu G., Gottlinger H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. U.S.A. 97:2000;13063-13068
44. Suikkanen S., Antila M., Jaatinen A., Vihinen-Ranta M., Vuento M. Release of canine parvovirus from endocytic vesicles. Virology. 316:2003;267-280
45. Tattersall P., Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 46:1983;944-955
46. Tullis G.E., Burger L.R., Pintel D.J. The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J. Virol. 67:1993;131-141
47. Vihinen-Ranta M., Kakkola L., Kalela A., Vilja P., Vuento M. Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur. J. Biochem. 250:1997;389-394
48. Vihinen-Ranta M., Kalela A., Makinen P., Kakkola L., Marjomaki V., Vuento M. Intracellular route of canine parvovirus entry. J. Virol. 72:1998;802-806
49. Vihinen-Ranta M., Yuan W., Parrish C.R. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J. Virol. 74:2000;4853-4859
50. Vihinen-Ranta M., Wang D., Weichert W.S., Parrish C.R. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J. Virol. 76:2002;1884-1891
51. Yan Z., Zak R., Luxton G.W., Ritchie T.C., Bantel-Schaal U., Engelhardt J.F. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76:2002;2043-2053
52. Zadori Z., Szelei J., Lacoste M.C., Li Y., Gariepy S., Raymond P., Allaire M., Nabi I.R., Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell. 1:2001;291-302